MAP1LC3A and metabolic dysfunction-associated steatotic liver disease: Moreover, EA increased the level of LC3 and ATG5 while decreasing BECN 1, RIPK1, RIPK3, and MLKL compared to the HFD‐induced NAFLD rats (p‐value < 0.05).